Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc.

CURA.CN
Curaleaf Holdings, Inc.CA flagCanadian Securities Exchange
5.22
CAD
+0.44
- -
4.07BMarket Cap
Curaleaf Holdings, Inc.
CURA.CN
(Canadian Securities Exchange)

Recent

price

5.22

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Curaleaf Holdings, Inc. is a leading international provider of consumer cannabis products, operating through a vertically integrated business model that encompasses cultivation, processing, manufacturing, distribution, and retail. The company's product portfolio includes a broad range of cannabis offerings such as flower, pre-rolls, flower pods, dry-herb vaporizer cartridges; concentrates for vaporizing including pre-filled cartridges and disposable pens; concentrates for dabbing like distillate droppers; as well as edibles, mints, lozenges, tinctures, topical balms, lotions, and capsules. Curaleaf's brands include Curaleaf, Select, Grassroots, JAMS, Find, and Zero Proof, serving medical and adult-use markets primarily in the United States with operations in approximately 17 states, alongside international presence, particularly in Europe. The company focuses on populated, limited-license states that offer regulatory advantages and pricing power, including Arizona, Connecticut, Florida, Illinois, Maryland, Massachusetts, Nevada, New York, New Jersey, North Dakota, Ohio, and Pennsylvania. Founded in 2010 and headquartered in Wakefield, Massachusetts, Curaleaf operates 151 dispensaries, 19 cultivation sites, and 20 manufacturing facilities. Recent major company developments include the strategic acquisition of The Cannabist Company's Virginia assets, comprising a fully operational cultivation facility and five retail dispensaries, with rights for an additional dispensary, expected to close in early 2026. In mid-2025, Curaleaf completed a buyout of the minority partner in Curaleaf International Holdings Limited, bringing its ownership of the European holding company to 100%, thereby strengthening its control and strategic alignment across international markets. The company has launched new national product innovations such as the hemp THC energy drink Select FormulaX, the vape innovation Select ACE, and a new pre-roll brand, Anthem. Curaleaf's "Return to Our Roots" strategic plan initiated in 2024 has focused on enhancing product quality, expanding margins, optimizing cash flow, leveraging proprietary genetics programs, expanding selective retail locations, and investing in facility upgrades and automation. Additionally, Curaleaf has successfully reduced acquisition-related debt and secured an upsized revolving credit facility to increase financial flexibility, supporting ongoing growth and international expansion efforts. These operational improvements and tactical shifts position Curaleaf for resilience and growth amid dynamic market conditions.